Internal Medicine, Endocrinology, Diabetes, & Metabolism · Boynton Beach, FL
NPI
1184732489
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
10150 Hagen Ranch Rd, Ste 201
Boynton Beach, FL, 33437
Phone (561) 374-8969
Groups this clinician bills Medicare through
Medicare paid, 2024
$928K
18,565 services
Medicare patients, 2024
2,371
Average age 77
Drug cost, 2024
$5.5M
17,918 prescriptions
Company payments, 2025
$2,222
From 29 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael J Mellman was code 99458 (e&m - miscellaneous), 4,157 times for 422 patients. In total Michael J Mellman billed 18,565 services in 24 codes, and Medicare paid $928K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-07-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99458 E&M - Miscellaneous | Office | 4,157 | 422 | $34.16 | $142K |
| 99457 E&M - Miscellaneous | Office | 2,205 | 422 | $42.32 | $93K |
| 99454 E&M - Miscellaneous | Office | 1,997 | 413 | $40.20 | $80K |
| 99213 Office E&M - Established | Office | 1,965 | 1,098 | $70.82 | $139K |
| 99214 Office E&M - Established | Office | 1,658 | 740 | $104.61 | $173K |
| 99424 Chronic, Principal, and Transitional Care Management | Office | 1,507 | 394 | $72.41 | $109K |
| 36415 Venipuncture Blood Collection | Office | 1,376 | 766 | $6.32 | $8,694 |
| 99231 Hospital E&M - Subsequent | Facility | 995 | 232 | $43.21 | $43K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 528 | 305 | $54.50 | $29K |
| 99453 E&M - Miscellaneous | Office | 453 | 369 | $17.32 | $7,847 |
| 99203 Office E&M - New | Office | 351 | 351 | $87.87 | $31K |
| 99221 Hospital E&M - Initial | Facility | 320 | 262 | $72.69 | $23K |
| 99212 Office E&M - Established | Office | 239 | 199 | $40.75 | $9,740 |
| 96372 Injection Administration | Office | 170 | 15 | $11.52 | $1,959 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 168 | 168 | $14.27 | $2,397 |
By year: 2022 $411K for 7,689 services; 2023 $417K for 7,719 services; 2024 $928K for 18,565 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,376 | 766 | $6.32 | $8,694 |
Medicare prescription drug claims, 2024
In 2024, the drug Michael J Mellman prescribed most often to Medicare patients was Levothyroxine Sodium, with 2,326 prescriptions and refills. In total Michael J Mellman wrote 17,918 Medicare prescriptions that cost $5.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 2,326 | 6,775 | 702 | $28K |
| Metformin Hcl Generic | 1,336 | 3,825 | 431 | $9,937 |
| Glimepiride Generic | 1,145 | 3,319 | 358 | $12K |
| Ozempic Semaglutide | 945 | 1,620 | 244 | $1.5M |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 635 | 1,639 | 225 | $128K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 631 | 1,792 | 278 | $69K |
| Metformin Hcl Er Metformin Hcl | 599 | 1,709 | 193 | $6,336 |
| Synthroid Levothyroxine Sodium | 584 | 1,644 | 164 | $52K |
| Mounjaro Tirzepatide | 566 | 805 | 126 | $831K |
| Atorvastatin Calcium Generic | 531 | 1,569 | 171 | $5,214 |
| Jardiance Empagliflozin | 317 | 736 | 92 | $420K |
| Glipizide Er Glipizide | 279 | 789 | 88 | $5,061 |
| Methimazole Generic | 249 | 703 | 90 | $3,239 |
| Rosuvastatin Calcium Generic | 245 | 715 | 89 | $3,451 |
| Humalog Kwikpen U-100 Insulin Lispro | 213 | 574 | 89 | $86K |
Brand drugs: 7,380 claims; generic drugs: 9,210 claims; opioid claims: 19.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael J Mellman $2,222 ($2,222 in general payments such as food, travel and fees) from 29 companies. The largest payer was Corcept Therapeutics with $240.
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics CORT | 12 | $240 |
| Dexcom, Inc. DXCM | 19 | $213 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $208 |
| Novo Nordisk Inc NVO | 12 | $149 |
| Medtronic, Inc. MDT | 10 | $140 |
| Sequel Med Tech, LLC | 5 | $112 |
| Mannkind Corporation MNKD | 5 | $107 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $106 |
| CeQur Corporation | 1 | $93.61 |
| Abbott Laboratories ABT | 5 | $93.19 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.